Wordt geladen...
Prognostic model of survival outcomes in non-small cell lung cancer patients initiated on afatinib: pooled analysis of clinical trial data
OBJECTIVE: Several predictors of survival have been identified in EGFR-positive non-small cell lung cancer (NSCLC) patients treated with first generation EGFR inhibitors. Prognostic models of survival outcomes with afatinib have not been evaluated. METHODS: A prognostic tool for overall survival (OS...
Bewaard in:
| Gepubliceerd in: | Cancer Biol Med |
|---|---|
| Hoofdauteurs: | , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Chinese Anti-Cancer Association
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6713630/ https://ncbi.nlm.nih.gov/pubmed/31516754 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.20892/j.issn.2095-3941.2018.0474 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|